- Home
- NRSN vs COCH Comparison
NRSN vs COCH Comparison
Compare NRSN & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRSN | COCH |
|---|---|---|
| Founded | 2017 | 1995 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 24.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRSN | COCH |
|---|---|---|
| Price | $0.88 | $0.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $14.00 | $9.50 |
| AVG Volume (30 Days) | ★ 489.0K | 448.5K |
| Earning Date | 04-06-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.81 | $0.64 |
| 52 Week High | $2.60 | $2.25 |
Technical Indicators
Market Signals| Indicator | NRSN | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 37.38 | 50.34 |
| Support Level | $0.86 | $0.80 |
| Resistance Level | $1.24 | $0.86 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 7.89 | 59.29 |
Price Performance
Historical ComparisonAbout NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.